Verisk Analytics Vs. Keros Therapeutics Industry Stock Comparison

Buy

84

VRSK
Verisk Analytics

Last Price:

269.36

Seasonality Move:

4.73%

Sell

27

KROS
Keros Therapeutics

Last Price:

45.71

Seasonality Move:

-4.71%

Buy

84

Verisk Analytics (VRSK) is a Buy

Is Verisk Analytics a Buy, Sell or Hold?

The current Verisk Analytics [VRSK] share price is $269.56. The Score for VRSK is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
VRSK is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

Sell

27

Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRSK Stock Price Chart

What is Verisk Analytics's stock price today?

The Verisk Analytics share price today is $269.56
The current trend is moderately bullish and VRSK is experiencing slight selling pressure.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

The Keros Therapeutics share price today is $45.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.

VRSK Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	5.94	Buy
Relative Strength Index (14 RSI):	66.88	Buy
Chaikin Money Flow:	-304007	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(253.75 - 269.75)	Buy
Bollinger Bands (100):	(228.82 - 257.32)	Buy

KROS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.79	Sell
Relative Strength Index (14 RSI):	38.41	Sell
Chaikin Money Flow:	239305	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(45.72 - 49.1)	Sell
Bollinger Bands (100):	(49.87 - 64.91)	Sell

VRSK Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	270.19	Sell
20-day SMA:	264.88	Buy
50-day SMA:	249.47	Buy
200-day SMA:	240.72	Buy
8-day EMA:	269.38	Buy
20-day EMA:	264.53	Buy
50-day EMA:	254.31	Buy
200-day EMA:	239.3	Buy

KROS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	45.61	Buy
20-day SMA:	47.29	Sell
50-day SMA:	51.65	Sell
200-day SMA:	47.07	Sell
8-day EMA:	45.93	Sell
20-day EMA:	47.34	Sell
50-day EMA:	50.89	Sell
200-day EMA:	50	Sell

Verisk Analytics Earnings Growth & VRSK Earnings Dates

Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.21 per share, an increase this year of $0.81 per share, and an increase next year of $0.83 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Verisk Analytics Technical Analysis

	Jun 14	Jun 17	Jun 18	Jun 20	Jun 21	Jun 24	Jun 25	Jun 26	Jun 27	Jun 28
	Jun
	14	17	18	20	21	24	25	26	27	28
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

	Jun 14	Jun 17	Jun 18	Jun 20	Jun 21	Jun 24	Jun 25	Jun 26	Jun 27	Jun 28
	Jun
	14	17	18	20	21	24	25	26	27	28
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):